“As an aside, I suspect the control arm in that trial will do very well. Would be interesting to how that matches to the -L treatment arm”
Umm…. let me fix it for you so that it reflects what my position has been for the last couple weeks.
As an aside, in the Survaxm iib trial, I suspect the control arm (and the Survaxm arm) will not do very well, due to the Survaxm iib trial needing to use all actual GBM patients and normal MGMT meth/unmeth ratios. Would be interesting to how that matches to the -L treatment arm.